This article has been cited by
1Testosterone Therapy in Patients with Treated and Untreated Prostate Cancer: Impact on Oncologic Outcomes
Jesse Ory,Ryan Flannigan,Colin Lundeen,James G. Huang,Peter Pommerville,S. Larry Goldenberg
Journal of Urology.2016;196(4)1082
[DOI]
2Hypogonadism
John T. Sigalos,Alexander W. Pastuszak,Mohit Khera
Medical Clinics of North America.2018;102(2)361
[DOI]
3Testosterone Therapy in Men With Prostate Cancer
Alan L. Kaplan,Jim C. Hu,Abraham Morgentaler,John P. Mulhall,Claude C. Schulman,Francesco Montorsi
European Urology.2016;69(5)894
[DOI]
4The consensus recommendations of a group of international experts on the fundamental concepts related to the issues of testosterone deficiency and its treatment.
Abraham Morgentaler,M. Zitzmann,A. M. Traish,A. W. Fox,T. H. Jones,M. Maggi,S. Arver,A. Aversa,J.C.N. Chan,A. S. Dobs,G. I. Hackett,W. J. Hellstrom,P. Lim,B. Lunenfeld,G. Mskhalaya,C. C. Schulman,L. O. Torres
Obesity and metabolism.2016;13(3)15
[DOI]
5Investigating the basis of sexual dysfunction during late-onset hypogonadism
Tharu Tharakan,Saiful Miah,Channa Jayasena,Suks Minhas
F1000Research.2019;8(3)331
[DOI]
6Shifting the Paradigm of Testosterone Replacement Therapy in Prostate Cancer
Michael A. Bell,Jeffrey D. Campbell,Gregory Joice,Nikolai A. Sopko,Arthur L. Burnett
The World Journal of Men's Health.2018;36(2)103
[DOI]
7Editorial Comment
Alan M. Nieder
Urology.2016;94(2)187
[DOI]
8Testosterone Therapy in a Man with Intermediate-risk Prostate Cancer: Pro
Abraham Morgentaler
European Urology Focus.2017;3(4-5)316
[DOI]
9Trends in Testosterone Therapy use in Prostate Cancer Survivors in the United States
Tony Chen,Shufeng Li,Michael L. Eisenberg
The Journal of Sexual Medicine.2021;18(8)1346
[DOI]
10Testosterone Therapy for High-risk Prostate Cancer Survivors: A Systematic Review and Meta-analysis
Fiona Teeling,Nicholas Raison,Majed Shabbir,Tet Yap,Prokar Dasgupta,Kamran Ahmed
Urology.2019;126(8)16
[DOI]
11Recommandations pratiques pour la prise en charge du déficit en testostérone
C. Burte,H. Lejeune,A. Faix,P. Desvaux,T. Almont,B. Cuzin,E. Huyghe
Progrès en Urologie.2021;31(8-9)458
[DOI]
12Testosterone Therapy Can be Given to Men with No Concern that it will Promote Prostate Cancer Development or Progression
Abraham Morgentaler
Journal of Urology.2016;196(4)985
[DOI]
13The Role of Testosterone Therapy in the Setting of Prostate Cancer
Katherine M. Rodriguez,Alexander W. Pastuszak,Mohit Khera
Current Urology Reports.2018;19(8)985
[DOI]
14Fundamental Concepts Regarding Testosterone Deficiency and Treatment
Abraham Morgentaler,Michael Zitzmann,Abdulmaged M. Traish,Anthony W. Fox,T. Hugh Jones,Mario Maggi,Stefan Arver,Antonio Aversa,Juliana C.N. Chan,Adrian S. Dobs,Geoffrey I. Hackett,Wayne J. Hellstrom,Peter Lim,Bruno Lunenfeld,George Mskhalaya,Claude C. Schulman,Luiz O. Torres
Mayo Clinic Proceedings.2016;91(7)881
[DOI]
15Testosterone Deficiency: A Review and Comparison of Current Guidelines
Jethro C.C. Kwong,Yonah Krakowsky,Ethan Grober
The Journal of Sexual Medicine.2019;16(6)812
[DOI]
16Testosterone Deficiency: A Review and Comparison of Current Guidelines
Abdulmaged M. Traish,Abraham Morgentaler
The Journal of Sexual Medicine.2019;16(6)321
[DOI]
17PICO: Testosteronsuppletie bij prostaatcarcinoom na curatieve behandeling of onder active surveillance
Jeroen Kolenburg,P. de Vries
Tijdschrift voor Urologie.2020;10(8)165
[DOI]
18Testosterone Therapy Among Prostate Cancer Survivors
Taylor M. Nguyen,Alexander W. Pastuszak
Sexual Medicine Reviews.2016;4(4)376
[DOI]
19Terapia con testosterone nell’uomo con patologia benigna o maligna della prostata
Giulia Rastrelli,Mario Maggi,Linda Vignozzi
L'Endocrinologo.2021;22(2)146
[DOI]
20Recommendations on the diagnosis, treatment and monitoring of testosterone deficiency in men
Bruno Lunenfeld,George Mskhalaya,Michael Zitzmann,Giovanni Corona,Stefan Arver,Svetlana Kalinchenko,Yuliya Tishova,Abraham Morgentaler
The Aging Male.2021;24(1)119
[DOI]
21Déficit en testostérone. Quels bénéfices et risques et pour quels patients ?
A. Faix,B. Cuzin,P. Desvaux,E. Huyghe,H. Lejeune,T. Almond,C. Burté
Sexologies.2021;30(3)157
[DOI]
22Testosterone replacement therapy (TRT) and prostate cancer: An updated systematic review with a focus on previous or active localized prostate cancer
Louis Lenfant,Priscilla Leon,Géraldine Cancel-Tassin,Marie Audouin,Frédéric Staerman,Morgan Rouprêt,Olivier Cussenot
Urologic Oncology: Seminars and Original Investigations.2020;38(8)661
[DOI]
23Safety of testosterone therapy in men with prostate cancer
Abraham Morgentaler,Monica Caliber
Expert Opinion on Drug Safety.2019;18(11)1065
[DOI]
24Reverse intermittent androgen deprivation therapy: Prostate cancer and hypopituitarism
George Hill,Raj Persad,Stefanos Bolomytis
Journal of Clinical Urology.2020;18(11)205141582092323
[DOI]
25The History of Testosterone and the Evolution of its Therapeutic Potential
Abraham Morgentaler,Abdulmaged Traish
Sexual Medicine Reviews.2020;8(2)286
[DOI]
26Testosterone Therapy and Prostate Cancer
Emily Davidson,Abraham Morgentaler
Urologic Clinics of North America.2016;43(2)209
[DOI]
27The effects of testosterone replacement therapy on the prostate: a clinical perspective
Saiful Miah,Tharu Tharakan,Kylie A Gallagher,Taimur T Shah,Mathias Winkler,Channa N Jayasena,Hashim U Ahmed,Suks Minhas
F1000Research.2019;8(2)217
[DOI]
28Variation in Testosterone Levels and Health-related Quality of Life in Men Diagnosed With Prostate Cancer on Active Surveillance
Andrew Cohen,Brittany Lapin,Chi H. Wang,Brian Helfand,David Victorson,Kristian Novakovic
Urology.2016;94(2)180
[DOI]
29The role of androgen therapy in prostate cancer: from testosterone replacement therapy to bipolar androgen therapy
Tao Xie,Xian-Lu Song,Chong Wang,Yu-Zhong Yu,Jing-Quan Wang,Zhe-Sheng Chen,Shan-Chao Zhao
Drug Discovery Today.2021;26(5)1293
[DOI]
30Prostate magnetic resonance imaging findings in patients treated for testosterone deficiency while on active surveillance for low-risk prostate cancer
Takeshi Hashimoto,Krishnan Rahul,Toshikazu Takeda,Nicole Benfante,John P. Mulhall,Hedvig Hricak,James A. Eastham,Hebert Alberto Vargas
Urologic Oncology: Seminars and Original Investigations.2016;34(12)530.e9
[DOI]
31Late-onset hypogonadism: Prostate safety
Eduardo P. Miranda,Luiz Otávio Torres
Andrology.2020;8(6)1606
[DOI]
32Testosterone Replacement Therapy in Men with Untreated or Treated Prostate Cancer: Do We Have Enough Evidences?
Myong Kim,Seok-Soo Byun,Sung Kyu Hong
The World Journal of Men's Health.2021;39(4)705
[DOI]
33Strategies for Testosterone Therapy in Men with Metastatic Prostate Cancer in Clinical Practice: Introducing Modified Bipolar Androgen Therapy
Abraham Morgentaler
Androgens: Clinical Research and Therapeutics.2020;1(1)76
[DOI]
34Strategies for Testosterone Therapy in Men with Metastatic Prostate Cancer in Clinical Practice: Introducing Modified Bipolar Androgen Therapy
Amarnath Rambhatla,Jacob Rajfer
Androgens: Clinical Research and Therapeutics.2018;1(1)767
[DOI]
35Letter to the editor: Questioning the evidence behind the Saturation Model for testosterone replacement therapy in prostate cancer
Abraham Morgentaler,Abdulmaged M. Traish
Investigative and Clinical Urology.2020;61(4)452
[DOI]
36Testosterone replacement therapy reduces biochemical recurrence after radical prostatectomy
Thomas E. Ahlering,Linda My Huynh,Maxwell Towe,Kaelyn See,Joshua Tran,Kathryn Osann,Farouk M. el Khatib,Faysal A. Yafi
BJU International.2020;126(1)91
[DOI]
37Late-onset Hypogonadism and Testosterone Therapy – A Summary of Guidelines from the American Urological Association and the European Association of Urology
Mikkel Fode,Andrea Salonia,Suks Minhas,Arthur L. Burnett,Alan W. Shindel
European Urology Focus.2019;5(4)539
[DOI]
38Testosterone, testosterone therapy and prostate cancer
A. Yassin,K. AlRumaihi,R. Alzubaidi,S. Alkadhi,A. Al Ansari
The Aging Male.2019;22(4)219
[DOI]
39Questioning the evidence behind the Saturation Model for testosterone replacement therapy in prostate cancer
Jin Wook Kim
Investigative and Clinical Urology.2020;61(3)242
[DOI]
40Updated Review of Testosterone Replacement Therapy in the Setting of Prostate Cancer
Michael Polchert,Igor Voznesensky,Ayman Soubra,Wayne J.G. Hellstrom
Androgens: Clinical Research and Therapeutics.2021;2(1)36
[DOI]
41Effects of Testosterone on Benign and Malignant Conditions of the Prostate
Amin S. Herati,Taylor P. Kohn,Peter R. Butler,Larry I. Lipshultz
Current Sexual Health Reports.2017;9(2)65
[DOI]
42Bipolar Androgen Therapy in Prostate Cancer (Update)
Eric M. Lo,Adithya Balasubramanian,Alexander W. Pastuszak,Mohit Khera
The Journal of Sexual Medicine.2020;17(5)831
[DOI]
43Bipolar Androgen Therapy in Prostate Cancer (Update)
Daniel de Freitas G. Soares,Ernani Luis Rhoden,Abraham Morgentaler
The Journal of Sexual Medicine.2017;17(5)285
[DOI]
44Testosterone Therapy in Men with Biochemical Recurrence and Metastatic Prostate Cancer: Initial Observations
Abraham Morgentaler,Alejandro Abello,Glenn Bubley
Androgens: Clinical Research and Therapeutics.2021;2(1)121
[DOI]
45Testosterone Therapy Can be Given to Men with No Concern that it will Promote Prostate Cancer Development or Progression
Martin E. Gleave,Laurence Klotz
Journal of Urology.2016;196(4)986
[DOI]
46Risk of Testosterone Flare in the Era of the Saturation Model: One More Historical Myth
Yonah Krakowsky,Abraham Morgentaler
European Urology Focus.2019;5(1)81
[DOI]
47Diagnosis and Treatment of Testosterone Deficiency: Updated Recommendations From the Lisbon 2018 International Consultation for Sexual Medicine
Abraham Morgentaler,Abdulmaged Traish,Geoffrey Hackett,T. Hugh Jones,Ranjith Ramasamy
Sexual Medicine Reviews.2019;7(4)636
[DOI]
Feedback

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal